RALEIGH, N.C., July 25, 2013 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq: BAXS ) announced today that it plans to release second quarter 2013 financial and operating results after market close on Thursday, August 8, 2013. Ken Reali, President and Chief Executive Officer and Joe Slattery, Chief Financial Officer, will host a conference call starting at 4:30 pm ET on the same day. To listen to the conference call on your telephone, please dial (877) 312-8823 for domestic callers and (253) 237-1182 for international callers approximately ten minutes prior to the start time. The call will be concurrently webcast. To access the live audio broadcast or archived recording, use the following link at http://ir.baxanosurgical.com/eventdetail.cfm?eventid=132615 .
About Baxano Surgical, Inc.
Baxano Surgical, Inc. is a medical device company focused on designing, developing, and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region. Baxano Surgical currently markets the AxiaLIF ® family of products for single and two level lower lumbar fusion, the VEO TM lateral access and interbody fusion system, and the iO-Flex® system, a proprietary set of flexible instruments used by surgeons during spinal decompression procedures. Baxano Surgical was founded in May 2000 and is headquartered in Raleigh, North Carolina. For more information, visit www.baxanosurgical.com .
Investors: Baxano Surgical, Inc. Joseph P. Slattery, 866-256-1206 Executive Vice President and Chief Financial Officer Westwicke Partners Mark Klausner, 443-213-0501
